NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 3 Aug 2026, 11:48 am

Analysts/Institutional Investor Meet/Con. Call Updates

Aarti Pharmalabs Limited · AARTIPHARM

✦ AI SummaryResults

Aarti Pharmalabs Limited has informed the Exchange about the schedule of an earnings conference call to discuss the Q1 FY27 financial results.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

AARTIPHARMA_03082026114744_Intimation_APLsigned.pdf

pdf

Download →
View document text
August 03, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Intimation of Earnings Conference Call Ref: Regulation 30 of the SEBI (LODR) Regulations, 2015 This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday, August 10, 2026, at 4:00 P.M. (IST) to discuss the Company’s Q1 FY27 financial results. Please find attached herewith Invitation for the same. Kindly take the same on your record. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565 Encl. a/a. CONCALL INVITE 360 ONE CM Research shall hold a Conference Call of Aarti Pharmalabs Limited to discuss the 1QFY27 Results on Monday, 10th August 2026 at 16:00 Hrs IST The Management Team will be represented by: Mr. Rashesh Gogri – Chairman Ms. Hetal Gogri Gala - Vice Chairperson & Managing Director Mr. Piyush Lakhani – Chief Financial Officer You are cordially invited Diamond Pass Link https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0531503&linkSecuritySt ring=4920a08ab Universal Dial-in Numbers +91 22 6280 1222 / +91 22 7115 8123 International Toll Free: Argentina: 0080014243444 | Australia: 0080014243444 | Belgium: 0080014243444 | Canada: 01180014243444 China: 4008428405 | | France: 0800914745 | Germany: 0080014243444 | Hong Kong: 800964448 Italy: 0080014243444 | Japan: 00531161110 | Netherlands: 08000229808 | Poland: 008001124248 Singapore: 8001012045 | South Korea: 00180014243444 | Sweden: 0080014243444 Thailand: 00180014243444 | UK: 08081011573 | USA: 18667462133 For further information, please contact Mr. Rohit Bhat / Mr. Maulik Varia 360 ONE Capital Market Research +91 22 4031 7150 / +91-22-4031 7275 rohit.bhat@360.one / maulik.varia@360.one